Argo admits disappointment as it records a Q1 loss
Argo posted a loss for the first quarter of 2020, but said it remains committed to its long term strategy for delivering shareholder value.
Argo made a loss of $18.8 million in Q1 2020, compared to the $91.2 million profit recorded in Q1 2019.
It reported gross written premium of $825.9 million in Q1 2020, up from $760.8 million in the same period of 2019. Its combined ratio increased to 103.2 percent, from 94.7 percent in Q1 2019.
Kevin Rehnberg, Argo’s chief executive officer, admitted the re/insurer was not satisfied with its overall performance, despite its premium growth and positive operating performance. “While we expect the premium and loss impact of COVID-19 to be challenging in 2020, we are committed to maintaining financial strength and implementing our strategy to drive long-term shareholder value,” he said. That strategy comprises “a focused review of our businesses; investment where there is significant opportunity; and a focus on maximising underwriting profitability.”
2 September 2025 Reflecting on SiriusPoint’s transformative journey, Scott Egan, CEO, emphasises the power of culture and marginal gains in steering performance enhancement, encapsulated in his philosophy of “chasing the 1%”.
18 February 2021 Argo Group International Holdings reported a significant year on year increase in its losses in 2020 but insisted it was making progress improving efficiency in the business.
4 August 2020 Argo Group made a small loss in the second quarter of 2020 but insisted its results show its underlying financial strength is improving, despite the challenging circumstances presented by COVID-19.
18 February 2021 Argo Group International Holdings reported a significant year on year increase in its losses in 2020 but insisted it was making progress improving efficiency in the business.
4 August 2020 Argo Group made a small loss in the second quarter of 2020 but insisted its results show its underlying financial strength is improving, despite the challenging circumstances presented by COVID-19.